loader
Please Wait
Applying Filters...

Euroapi Company Header Euroapi Company Header

X

Annual Sales of RITUXAN reported using PharmaCompass' compilation of Annual Reports of Global Pharmaceutical Companies.

Client Email Product
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 MabThera/Rituxan (2)

02 Rituximab BS (KHK) (1)

03 Ruxience (1)

URL Supplier Web Content
MabThera/Rituxan
Oncology
CHF
4,890
5,191
5,037
5,347
-310
-6
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
MabThera/Rituxan
Immunology
CHF
1,587
1,561
1,635
1,608
27
2
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
Rituxan/Gazyva Revenues
Oncology
USD
1,132
1,603
1,132
1,603
-471
-29
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
Rituximab BS (KHK)
Oncology
YEN
12
10
112
92
20
22
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
Ruxience
Oncology
USD
170
-1
170
-1
171
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
MabThera/Rituxan
Oncology
CHF
3,206
4,890
3,572
5,448
-1,876
-34
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
MabThera/Rituxan
Immunology
CHF
1,017
1,587
1,133
1,768
-635
-36
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
Rituximab BS (KHK)
Oncology
YEN
11
12
95
112
-17
-5
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
MabThera/Rituxan
Oncology
CHF
1,999
3,206
2,151
3,398
-1,247
-38
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
MabThera/Rituxan
Immunology
CHF
566
1,017
609
1,078
-469
-44
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Post Enquiry
POST ENQUIRY